Pimobendan

HCID 4823CAS 118428-37-8

基本情報

標準SMILES: COc1ccc(-c2nc3ccc(C4=NNC(=O)CC4C)cc3[nH]2)cc1
InChIKey: GLBJJMFZWDBELO-UHFFFAOYSA-N
分子式: C19H18N4O2
平均分子量: 334.4 g/mol
単同位体質量: 334.14297582

概要

Pimobendan is a member of benzimidazoles and a pyridazinone. It has a role as a vasodilator agent, a cardiotonic drug and an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor.

名称と識別子

優先名称: Pimobendan
IUPAC: 3-[2-(4-methoxyphenyl)-3H-benzimidazol-5-yl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one
英語名: l-Pimobendan
分子式: C19H18N4O2
分子量: 334.37

名称と別名

pimobendan74150-27-9pimobendaneAcardidl-PimobendanVetmedinPimobendanumRacemic pimobendanUD-CG-115BSUD-CG-115UDCG-115Pimobendan,USP

名称をさらに表示

i-Pimobendanl-Pimobendan

Vetmedin Solution34AP3BBP9TDTXSID8048280FORTEKOR PLUS COMPONENT PIMOBENDANCHEBI:320033(2H)-Pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methyl-4,5-dihydropyridazin-3(2H)-oneUD-CG115

データベース識別子

CAS: 118428-37-8、118428-38-9、74150-27-9
PubChem CID: 4823
DTXSID: DTXSID8048280
ChEMBL: CHEMBL24646
ChEBI: CHEBI:32003
UNII: 34AP3BBP9T、613JXV89SU、9HTU209Z0N
EC Number: 640-420-7
Nikkaji: J34.390K

物性

構造計算による物性

XLogP: 2.7
極性表面積: 79.4 Å²
水素結合供与体数: 2
水素結合受容体数: 4
回転可能結合数: 3
重原子数: 25
形式電荷: 0
複雑度: 530

実験および物理化学的性質

Animal Drugs · 2 件

FDA approved animal drugs -> Active ingredient

Pharmaceuticals -> UK Veterinary Medicines Directorate List

物理化学的性質

沸点: 471.18 °C · 471.18°C (rough estimate)
比重(密度): 1.2421 · 1.2421 (rough estimate)
屈折率: 1.662 · 1.6620 (estimate)
酸解離定数(Pka): 10.21 · 10.21±0.10(Predicted)

安全と法規制

GHS分類

GHS Classification · 4 件

Danger

H301 (20%): Toxic if swallowed [Danger Acute toxicity, oral]

P203, P261, P264, P270, P271, P273, P280, P301+P316, P301+P317, P304+P340, P317, P318, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 10 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory InformationPimobendan: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Hazard Classes and CategoriesAcute Tox. 3 (20%)

化学と産業

薬理情報

ATC CodeQC - Cardiovascular system

MeSH Pharmacological Classification · 3 件

Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).

Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases.

Drugs used to cause dilation of the blood vessels.

サプライヤー1 社

河南天孚化工有限公司+86-0371-55170693 +86-19937530512 · [email protected]